Formulation and Evaluation of Micro Beads of Clonidine for the Treatment of Anxiety and Hypertensive Disorder
Abstract
A chronic medical condition known as hypertension (HT) is characterised by persistently high blood pressure (BP) in the arteries. Although HT is initially asymptomatic, it eventually develops into a significant risk factor for renal, cardiovascular, and cerebrovascular conditions, which in turn are major contributors to morbidity and mortality in industrialised nations. A complicated disorder called HT is thought to affect more than one-fourth of adult humans worldwide. Both its pathophysiology (primary and secondary HT) and the measurements of the resting blood pressure (elevated systolic, diastolic, and pulse pressure) are used to categories it. It results from a complex interplay between genes and a number of environmental risk factors, including as ageing, smoking, inactivity, being overweight or obese, eating too much salt, stress, depression, and anxiety. Millions of people are affected by anxiety and depressive disorders each year, which are the most often diagnosed mental illnesses. These conditions are both characterised by emotional, cognitive, psychomotor, and neurovegetative symptoms. Additionally, stress at work has been identified as a significant risk factor for heart disease (CVD) and HT. Despite the fact that numerous writers have looked into and proposed connections between HT, stress, anxiety, and depression over the past few decades, a complete knowledge of the underlying pathophysiological mechanisms has not yet been attained, particularly with regards to young people. The purpose of this study was to examine the role that stress and anxiety from the workplace play in the HT development of young students of health care professions as well as any potential links to early CVDs.
Keywords: Blood pressure, Anxiety, Work-related stress, Students, Health care professions, Health promotion, Workplace, Occupational medicine
Keywords:
Blood pressure, Anxiety, Work-related stress, Students, Health care professions, Health promotion, Workplace, Occupational medicineDOI
https://doi.org/10.22270/jddt.v13i7.5920References
Jinuk K, Jinyoung K, Dongmyung P, Haksoo H. A novel synthesis method for an open-cell microsponge polyimide for heat insulation. Polymer 2015; 56:68-72 https://doi.org/10.1016/j.polymer.2014.06.090
Jelvehgari M, Siahi-Shadbad MR, Azarmi S, Martin GP and Nokhodchi A. The microsponge delivery system of benzoyl peroxide: Preparation, characterization and release studies. International Journal of Pharmaceutics 2006; 308(1-2):124-132. https://doi.org/10.1016/j.ijpharm.2005.11.001
Iwai S, Sawa Y, Ichikawa H, Taketani S, Uchimura E, Chen G,Hara M, Miyake J and Matsuda H. Biodegradable polymer with collagen microsponge serves as a new bioengineered cardiovascular prosthesis. The Journal of Thoracic and Cardiovascular Surgery 2004; 128(3):472-479. https://doi.org/10.1016/j.jtcvs.2004.04.013
Siepmann J, Siepmann F. Microparticles used as drug delivery systems. Program Colloid Polymer Sciences 2006; 133:15-21. https://doi.org/10.1007/3-540-32702-9_3
Majeti N, Ravi Kumar V. Nano and microparticles as controlled drug delivery devices. Journal of Pharm Pharmaceutical Sci 2000; 3(2):234-258.
Dey NS, Majumdar S, Rao MEB. Multiparticulate drug delivery systems for controlled release. Tropical Journal of Pharmaceutical Research 2009; 1826-1837. https://doi.org/10.4314/tjpr.v7i3.14692
Reddy JR, Gnanaprakash K, Badarinath AV, Madhusudhanachetty C. Formulation and evaluation of microparticles of metronidazolein. Journal of Pharmaceutical Sciences and Research2009; 1:131-136.
Padalkar AN, Shahi1 SR, Thube MW. Microparticles: an approach for betterment of drug delivery system. Asian Journal of Pharmaceutical Education and Research 2011; 3:23-45.
Bhadke SE. Formulation and development of repaglinide microparticles by ionotropic gelation technique. Thesis at Dept of Pharmaceutical sciences Hubli. 2007; 1-129.
Wagner JG. Dissolution testing. Clin. Pharm, Drug Intelligence Publications,. 1970; 4:32. https://doi.org/10.1177/106002807000400202
Thulluru A, Mohan Varma M, Setty CM, Anusha A, Chamundeeswari P, Sanufar S. Formulation, in vitro and in vivo evaluation of pioglitazone hydrochloride-effervescent gastro retentive floating hydrophilic matrix tablets. International Journal of PharmTech Research 2016; 9(7):388-98.
Chowdary KPR, Srirama Murthy A. Formulation of celecoxib in to immediate release tablets. Indian Drugs 1985; 22: 538.
Wan SH, Pentikäinen PJ, Azarnoff DL. Bioavailability of aminosalicylic acid and its various salts in humans III: absorption from tablets. Journal of Pharmaceutical Sciences 1974; 63(5):708-11. https://doi.org/10.1002/jps.2600630512
Leonards JR. The influence of solubility on the rate of gastrointestinal absorption of aspirin. Clinical Pharmacology & Therapeutics 1963; 4(4):476-9. https://doi.org/10.1002/cpt196344476
Dawra VK, Liang Y, Shi H, Bass A, Hickman A, Terra SG, Zhou S, Cutler D, Sahasrabudhe V. A PK/PD study comparing twice-daily to once-daily dosing regimens of ertugliflozin in healthy subjects. International Journal of Clinical Pharmacology and Therapeutics 201957(4):207. https://doi.org/10.5414/CP203343
Aristidou A, San K, Bennett G. Modification of central metabolic pathway in Escherichia coli to reduce acetate accumulation by heterologous expression of the Bacillus subtilis acetolactate synthase gene. Biotechnol Bioeng 1994; 44:944-951. https://doi.org/10.1002/bit.260440810
Aristidou A, San K, Bennett N. Metabolic engineering of Escherichia coli to enhance recombinant protein production through acetate reduction. Biotechnology Progress1995; 11:475-478. https://doi.org/10.1021/bp00034a019
Atkinson B, Mavituna F. Process biotechnology, In Biochemical engineering and Biotechnology Handbook. (2"d ed.) McMillan, London. 1995; 115-167.
Binder F, Huber O, Bock A. Cyclodextrin glycosyl transferase from Klebsiella pneumoniae M5a1: cloning nucleotide sequence and expression. Bobo, W.S. US patent, 1993.
Brown NO, Butler DL, Chiang PK. Stabilization of thymopentin and preservation of its pharmacological properties by 2-hydroxypropyl-beta-cyclodextrin. Journal of Pharmacy and Pharmacology 1993; 5:666. https://doi.org/10.1111/j.2042-7158.1993.tb05675.x
Buschman HJ. In Proceedings of the eighth Int. symposium on cyclodextrins. Eds. Szejtli, J., Szente, L. Kluwer academic.1996; 547
Published
Abstract Display: 411 
PDF Downloads: 534 PDF Downloads: 131 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.